Tango Therapeutics TNGX
Ownership & positioning
Who holds it, who is betting against it, and where the big money is moving
Short-sale volume as % of daily volume
Large-order net flow, last 20 sessions
Net of large-order buying minus selling, in USD. Over this window: +$12.21M (9 inflow days, 11 outflow days).
Net flow by order size, last 20 sessions
Super/Big orders approximate institutional-size trades; Mid/Small approximate retail-size trades. Net buy minus sell value in each bucket, summed over the window.
The five largest holders on file together own 44.5% of shares outstanding.
Largest holders
By investor type
Reported short interest has risen from 25.61% to 28.61% of float over the last 6 biweekly reports (14 Aug 2026 to 30 Oct 2026).
Recent institutional activity
| Holder | Type | Period | Share change | New stake |
|---|---|---|---|---|
| FMR | Mutual Fund | 2026/Q3 | +12,953,285 | 14.9% |
| State Street Global Advisors | Mutual Fund | 2026/Q3 | +1,335,595 | 4.3% |
| BlackRock | Mutual Fund | 2026/Q3 | +704,625 | 7.8% |
| Artal Group S.A. | VC/PE Fund | 2026/Q3 | +604,717 | 4.0% |
| Vanguard Capital Management, LLC | Mutual Fund | 2026/Q3 | +560,265 | 3.8% |
| T. Rowe Price Group, Inc. | Mutual Fund | 2026/Q3 | +5,271,521 | 3.9% |
| The Goldman Sachs Group, Inc. | Public Company | 2026/Q3 | +4,770,352 | 5.7% |
| BlackRock | Mutual Fund | 2026/Q3 | +3,690,399 | 7.4% |
| Farallon Capital Management, L.L.C. | Hedge Fund | 2026/Q3 | +3,179,589 | 7.2% |
| Janus Henderson Group plc | Mutual Fund | 2026/Q3 | +2,661,380 | 3.0% |
| Perceptive Advisors LLC | VC/PE Fund | 2026/Q3 | +2,568,847 | 2.0% |
| FMR | Mutual Fund | 2026/Q3 | +2,427,419 | 7.3% |
| Seven Fleet Capital Management LP | Hedge Fund | 2026/Q3 | +2,425,484 | 1.9% |
| Paradigm Biocapital Advisors LP | Hedge Fund | 2026/Q3 | +2,347,844 | 3.8% |
| Commodore Capital LP | Hedge Fund | 2026/Q3 | +2,250,000 | 1.3% |
Institutional buy/sell activity by reporting period, largest moves first.
Insider transactions
| Date | Insider | Title | Transaction | Shares | Price | Held after |
|---|---|---|---|---|---|---|
| 1 Nov 2026 | Jessica Newcomb | Automatic Disposition | -7,031 | $22.98 | 8,424 | |
| 1 Nov 2026 | Adam Crystal | President of Research & Development | Derivative Exercise and Sale | -5,000 | $22.99 | 17,230 |
| 30 Sep 2026 | Adam Crystal | President of Research & Development | Derivative Exercise and Sale | -27,000 | $25.32 | 17,230 |
| 21 Sep 2026 | Jessica Newcomb | Automatic Disposition | -8,200 | $25.17 | 15,455 | |
| 31 Aug 2026 | Adam Crystal | President of Research & Development | Derivative Exercise and Sale | -27,000 | $22.37 | 17,230 |
| 2 Aug 2026 | Adam Crystal | President of Research & Development | Derivative Exercise and Sale | -27,000 | $27.35 | 17,230 |
| 30 Jun 2026 | Adam Crystal | President of Research & Development | Derivative Exercise and Sale | -27,000 | $30.25 | 17,230 |
| 18 Jun 2026 | Robert Azelby | Independent Chairperson | Other Acquisition | +5,740 | – | 5,740 |
| 18 Jun 2026 | Robert Azelby | Independent Chairperson | Other Derivative Acquisition | +35,910 | $27.97 | 35,910 |
| 16 Jun 2026 | Nextech Invest Ltd. | Intent to Sell (Form 144) | -3,766,081 | $30.10 | – | |
| 10 Jun 2026 | Daniella Beckman | Former Chief Financial Officer | Intent to Sell (Form 144) | -1,791,726 | $28.76 | – |
| 9 Jun 2026 | Daniella Beckman | Former Chief Financial Officer | Intent to Sell (Form 144) | -4,446 | $30.00 | – |
| 4 Jun 2026 | Mace Rothenberg | Independent Director | Other Acquisition | +4,000 | – | 4,000 |
| 4 Jun 2026 | Mace Rothenberg | Independent Director | Other Derivative Acquisition | +25,000 | $20.22 | 25,000 |
| 4 Jun 2026 | Lesley Calhoun | Independent Director | Other Acquisition | +4,000 | – | 4,000 |
| 4 Jun 2026 | Lesley Calhoun | Independent Director | Other Derivative Acquisition | +25,000 | $20.22 | 25,000 |
| 4 Jun 2026 | John Ketchum | Independent Director | Other Acquisition | +4,000 | – | 7,333 |
| 4 Jun 2026 | John Ketchum | Independent Director | Other Derivative Acquisition | +25,000 | $20.22 | 25,000 |
| 4 Jun 2026 | Sung Lee | Lead Independent Director | Other Acquisition | +570 | – | 22,870 |
| 4 Jun 2026 | Sung Lee | Lead Independent Director | Other Derivative Acquisition | +3,570 | $20.22 | 3,570 |
From Form 4/Form 144 filings. Negative share counts are disposals (sales, gifts, or shares withheld for taxes); positive are acquisitions.
Short interest, by report
| Report date | Shares short | % of float | Days to cover |
|---|---|---|---|
| 30 Oct 2026 | 48,239,154 | 28.6% | 9.7 |
| 15 Oct 2026 | 44,777,592 | 26.6% | 11.2 |
| 30 Sep 2026 | 44,500,110 | 26.4% | 12.5 |
| 15 Sep 2026 | 41,872,812 | 24.8% | 18.8 |
| 31 Aug 2026 | 42,627,550 | 25.3% | 19.7 |
| 14 Aug 2026 | 43,186,169 | 25.6% | 20.9 |
No comments yet — be the first to weigh in on TNGX.
Sign in to join the discussion.